| Dr Edward P Frothingham, MD | |
|
734 Elm St Sw, Albany, OR 97321-1934 | |
| (541) 812-5111 | |
| (541) 926-9360 |
| Full Name | Dr Edward P Frothingham |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 734 Elm St Sw, Albany, Oregon |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619918315 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | MD22047 (Oregon) | Primary |
| Entity Name | Mid-valley Healthcare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689625980 PECOS PAC ID: 2769391523 Enrollment ID: O20031111000297 |
News Archive
The Structural Genomics Consortium (SGC) and CHDI Foundation have entered into a unique open-access research collaboration to discover and characterize new drug targets for Huntington's disease (HD) using structural and chemical biology In this first partnership of its kind, SGC and CHDI have explicitly agreed not to file for patents on any of the collaborative research and to make all reagents and knowledge available without restriction to the wider research community, including pharmaceutical, biotech, and academic research groups.
Small particles are becoming a big business for the world's personal care products manufacturers according to an analysis of world patent activity published today by the IP Solutions business of Thomson Reuters. The new report, Can Nanotech Unlock the Fountain of Youth?, finds that the beauty industry has begun to make an aggressive foray into nanotechnology, using tiny molecular compounds to improve the performance of creams, sunscreens, shampoos and other personal-care products.
According to a new research, circulating tumor DNA can be used detect treatment options for ovarian cancer patients who don't benefit from chemotherapy.
CQ HealthBeat reports that even in jurisdictions that opt not to pursue the Medicaid expansion, the number of people who are left without insurance coverage will not be as large as expected. Meanwhile, Arkansas Gov. Mike Beebe signed his state's private insurance option plan into law while debate is ongoing in Pennsylvania, Texas, Florida and South Dakota.
Pharmspective, LLC today announced the release of its second syndicated report – Molecular Diagnostics Insights in Oncology. This new extensive survey of over 400 oncologists characterizes the emerging molecular diagnostics landscape and the role and influence of specific assays in clinical management and therapy selection.
› Verified 4 days ago
| Entity Name | Good Samaritan Hospital Corvallis |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962453134 PECOS PAC ID: 1557270725 Enrollment ID: O20031125000163 |
News Archive
The Structural Genomics Consortium (SGC) and CHDI Foundation have entered into a unique open-access research collaboration to discover and characterize new drug targets for Huntington's disease (HD) using structural and chemical biology In this first partnership of its kind, SGC and CHDI have explicitly agreed not to file for patents on any of the collaborative research and to make all reagents and knowledge available without restriction to the wider research community, including pharmaceutical, biotech, and academic research groups.
Small particles are becoming a big business for the world's personal care products manufacturers according to an analysis of world patent activity published today by the IP Solutions business of Thomson Reuters. The new report, Can Nanotech Unlock the Fountain of Youth?, finds that the beauty industry has begun to make an aggressive foray into nanotechnology, using tiny molecular compounds to improve the performance of creams, sunscreens, shampoos and other personal-care products.
According to a new research, circulating tumor DNA can be used detect treatment options for ovarian cancer patients who don't benefit from chemotherapy.
CQ HealthBeat reports that even in jurisdictions that opt not to pursue the Medicaid expansion, the number of people who are left without insurance coverage will not be as large as expected. Meanwhile, Arkansas Gov. Mike Beebe signed his state's private insurance option plan into law while debate is ongoing in Pennsylvania, Texas, Florida and South Dakota.
Pharmspective, LLC today announced the release of its second syndicated report – Molecular Diagnostics Insights in Oncology. This new extensive survey of over 400 oncologists characterizes the emerging molecular diagnostics landscape and the role and influence of specific assays in clinical management and therapy selection.
› Verified 4 days ago
| Entity Name | Samaritan North Lincoln Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306897491 PECOS PAC ID: 7911816301 Enrollment ID: O20040120000329 |
News Archive
The Structural Genomics Consortium (SGC) and CHDI Foundation have entered into a unique open-access research collaboration to discover and characterize new drug targets for Huntington's disease (HD) using structural and chemical biology In this first partnership of its kind, SGC and CHDI have explicitly agreed not to file for patents on any of the collaborative research and to make all reagents and knowledge available without restriction to the wider research community, including pharmaceutical, biotech, and academic research groups.
Small particles are becoming a big business for the world's personal care products manufacturers according to an analysis of world patent activity published today by the IP Solutions business of Thomson Reuters. The new report, Can Nanotech Unlock the Fountain of Youth?, finds that the beauty industry has begun to make an aggressive foray into nanotechnology, using tiny molecular compounds to improve the performance of creams, sunscreens, shampoos and other personal-care products.
According to a new research, circulating tumor DNA can be used detect treatment options for ovarian cancer patients who don't benefit from chemotherapy.
CQ HealthBeat reports that even in jurisdictions that opt not to pursue the Medicaid expansion, the number of people who are left without insurance coverage will not be as large as expected. Meanwhile, Arkansas Gov. Mike Beebe signed his state's private insurance option plan into law while debate is ongoing in Pennsylvania, Texas, Florida and South Dakota.
Pharmspective, LLC today announced the release of its second syndicated report – Molecular Diagnostics Insights in Oncology. This new extensive survey of over 400 oncologists characterizes the emerging molecular diagnostics landscape and the role and influence of specific assays in clinical management and therapy selection.
› Verified 4 days ago
| Entity Name | Samaritan Pacific Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174888010 PECOS PAC ID: 2466353529 Enrollment ID: O20040204000304 |
News Archive
The Structural Genomics Consortium (SGC) and CHDI Foundation have entered into a unique open-access research collaboration to discover and characterize new drug targets for Huntington's disease (HD) using structural and chemical biology In this first partnership of its kind, SGC and CHDI have explicitly agreed not to file for patents on any of the collaborative research and to make all reagents and knowledge available without restriction to the wider research community, including pharmaceutical, biotech, and academic research groups.
Small particles are becoming a big business for the world's personal care products manufacturers according to an analysis of world patent activity published today by the IP Solutions business of Thomson Reuters. The new report, Can Nanotech Unlock the Fountain of Youth?, finds that the beauty industry has begun to make an aggressive foray into nanotechnology, using tiny molecular compounds to improve the performance of creams, sunscreens, shampoos and other personal-care products.
According to a new research, circulating tumor DNA can be used detect treatment options for ovarian cancer patients who don't benefit from chemotherapy.
CQ HealthBeat reports that even in jurisdictions that opt not to pursue the Medicaid expansion, the number of people who are left without insurance coverage will not be as large as expected. Meanwhile, Arkansas Gov. Mike Beebe signed his state's private insurance option plan into law while debate is ongoing in Pennsylvania, Texas, Florida and South Dakota.
Pharmspective, LLC today announced the release of its second syndicated report – Molecular Diagnostics Insights in Oncology. This new extensive survey of over 400 oncologists characterizes the emerging molecular diagnostics landscape and the role and influence of specific assays in clinical management and therapy selection.
› Verified 4 days ago
| Entity Name | Albany General Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154372340 PECOS PAC ID: 9931097987 Enrollment ID: O20040310000310 |
News Archive
The Structural Genomics Consortium (SGC) and CHDI Foundation have entered into a unique open-access research collaboration to discover and characterize new drug targets for Huntington's disease (HD) using structural and chemical biology In this first partnership of its kind, SGC and CHDI have explicitly agreed not to file for patents on any of the collaborative research and to make all reagents and knowledge available without restriction to the wider research community, including pharmaceutical, biotech, and academic research groups.
Small particles are becoming a big business for the world's personal care products manufacturers according to an analysis of world patent activity published today by the IP Solutions business of Thomson Reuters. The new report, Can Nanotech Unlock the Fountain of Youth?, finds that the beauty industry has begun to make an aggressive foray into nanotechnology, using tiny molecular compounds to improve the performance of creams, sunscreens, shampoos and other personal-care products.
According to a new research, circulating tumor DNA can be used detect treatment options for ovarian cancer patients who don't benefit from chemotherapy.
CQ HealthBeat reports that even in jurisdictions that opt not to pursue the Medicaid expansion, the number of people who are left without insurance coverage will not be as large as expected. Meanwhile, Arkansas Gov. Mike Beebe signed his state's private insurance option plan into law while debate is ongoing in Pennsylvania, Texas, Florida and South Dakota.
Pharmspective, LLC today announced the release of its second syndicated report – Molecular Diagnostics Insights in Oncology. This new extensive survey of over 400 oncologists characterizes the emerging molecular diagnostics landscape and the role and influence of specific assays in clinical management and therapy selection.
› Verified 4 days ago
| Entity Name | Samaritan North Lincoln Hospital |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1306897491 PECOS PAC ID: 7911816301 Enrollment ID: O20061104000117 |
News Archive
The Structural Genomics Consortium (SGC) and CHDI Foundation have entered into a unique open-access research collaboration to discover and characterize new drug targets for Huntington's disease (HD) using structural and chemical biology In this first partnership of its kind, SGC and CHDI have explicitly agreed not to file for patents on any of the collaborative research and to make all reagents and knowledge available without restriction to the wider research community, including pharmaceutical, biotech, and academic research groups.
Small particles are becoming a big business for the world's personal care products manufacturers according to an analysis of world patent activity published today by the IP Solutions business of Thomson Reuters. The new report, Can Nanotech Unlock the Fountain of Youth?, finds that the beauty industry has begun to make an aggressive foray into nanotechnology, using tiny molecular compounds to improve the performance of creams, sunscreens, shampoos and other personal-care products.
According to a new research, circulating tumor DNA can be used detect treatment options for ovarian cancer patients who don't benefit from chemotherapy.
CQ HealthBeat reports that even in jurisdictions that opt not to pursue the Medicaid expansion, the number of people who are left without insurance coverage will not be as large as expected. Meanwhile, Arkansas Gov. Mike Beebe signed his state's private insurance option plan into law while debate is ongoing in Pennsylvania, Texas, Florida and South Dakota.
Pharmspective, LLC today announced the release of its second syndicated report – Molecular Diagnostics Insights in Oncology. This new extensive survey of over 400 oncologists characterizes the emerging molecular diagnostics landscape and the role and influence of specific assays in clinical management and therapy selection.
› Verified 4 days ago
| Entity Name | Mid-valley Healthcare Inc |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1689625980 PECOS PAC ID: 2769391523 Enrollment ID: O20061104000140 |
News Archive
The Structural Genomics Consortium (SGC) and CHDI Foundation have entered into a unique open-access research collaboration to discover and characterize new drug targets for Huntington's disease (HD) using structural and chemical biology In this first partnership of its kind, SGC and CHDI have explicitly agreed not to file for patents on any of the collaborative research and to make all reagents and knowledge available without restriction to the wider research community, including pharmaceutical, biotech, and academic research groups.
Small particles are becoming a big business for the world's personal care products manufacturers according to an analysis of world patent activity published today by the IP Solutions business of Thomson Reuters. The new report, Can Nanotech Unlock the Fountain of Youth?, finds that the beauty industry has begun to make an aggressive foray into nanotechnology, using tiny molecular compounds to improve the performance of creams, sunscreens, shampoos and other personal-care products.
According to a new research, circulating tumor DNA can be used detect treatment options for ovarian cancer patients who don't benefit from chemotherapy.
CQ HealthBeat reports that even in jurisdictions that opt not to pursue the Medicaid expansion, the number of people who are left without insurance coverage will not be as large as expected. Meanwhile, Arkansas Gov. Mike Beebe signed his state's private insurance option plan into law while debate is ongoing in Pennsylvania, Texas, Florida and South Dakota.
Pharmspective, LLC today announced the release of its second syndicated report – Molecular Diagnostics Insights in Oncology. This new extensive survey of over 400 oncologists characterizes the emerging molecular diagnostics landscape and the role and influence of specific assays in clinical management and therapy selection.
› Verified 4 days ago
| Entity Name | Samaritan Pacific Health Services Inc |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1801847066 PECOS PAC ID: 2466353529 Enrollment ID: O20061104000163 |
News Archive
The Structural Genomics Consortium (SGC) and CHDI Foundation have entered into a unique open-access research collaboration to discover and characterize new drug targets for Huntington's disease (HD) using structural and chemical biology In this first partnership of its kind, SGC and CHDI have explicitly agreed not to file for patents on any of the collaborative research and to make all reagents and knowledge available without restriction to the wider research community, including pharmaceutical, biotech, and academic research groups.
Small particles are becoming a big business for the world's personal care products manufacturers according to an analysis of world patent activity published today by the IP Solutions business of Thomson Reuters. The new report, Can Nanotech Unlock the Fountain of Youth?, finds that the beauty industry has begun to make an aggressive foray into nanotechnology, using tiny molecular compounds to improve the performance of creams, sunscreens, shampoos and other personal-care products.
According to a new research, circulating tumor DNA can be used detect treatment options for ovarian cancer patients who don't benefit from chemotherapy.
CQ HealthBeat reports that even in jurisdictions that opt not to pursue the Medicaid expansion, the number of people who are left without insurance coverage will not be as large as expected. Meanwhile, Arkansas Gov. Mike Beebe signed his state's private insurance option plan into law while debate is ongoing in Pennsylvania, Texas, Florida and South Dakota.
Pharmspective, LLC today announced the release of its second syndicated report – Molecular Diagnostics Insights in Oncology. This new extensive survey of over 400 oncologists characterizes the emerging molecular diagnostics landscape and the role and influence of specific assays in clinical management and therapy selection.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Edward P Frothingham, MD Po Box 1188, Corvallis, OR 97339-1188 Ph: (541) 812-5111 | Dr Edward P Frothingham, MD 734 Elm St Sw, Albany, OR 97321-1934 Ph: (541) 812-5111 |
News Archive
The Structural Genomics Consortium (SGC) and CHDI Foundation have entered into a unique open-access research collaboration to discover and characterize new drug targets for Huntington's disease (HD) using structural and chemical biology In this first partnership of its kind, SGC and CHDI have explicitly agreed not to file for patents on any of the collaborative research and to make all reagents and knowledge available without restriction to the wider research community, including pharmaceutical, biotech, and academic research groups.
Small particles are becoming a big business for the world's personal care products manufacturers according to an analysis of world patent activity published today by the IP Solutions business of Thomson Reuters. The new report, Can Nanotech Unlock the Fountain of Youth?, finds that the beauty industry has begun to make an aggressive foray into nanotechnology, using tiny molecular compounds to improve the performance of creams, sunscreens, shampoos and other personal-care products.
According to a new research, circulating tumor DNA can be used detect treatment options for ovarian cancer patients who don't benefit from chemotherapy.
CQ HealthBeat reports that even in jurisdictions that opt not to pursue the Medicaid expansion, the number of people who are left without insurance coverage will not be as large as expected. Meanwhile, Arkansas Gov. Mike Beebe signed his state's private insurance option plan into law while debate is ongoing in Pennsylvania, Texas, Florida and South Dakota.
Pharmspective, LLC today announced the release of its second syndicated report – Molecular Diagnostics Insights in Oncology. This new extensive survey of over 400 oncologists characterizes the emerging molecular diagnostics landscape and the role and influence of specific assays in clinical management and therapy selection.
› Verified 4 days ago
Adam B Paul, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 734 Elm St Sw, Albany, OR 97321 Phone: 541-812-5111 Fax: 541-812-5127 | |
Dr. Christina M. Miller, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1123 Hill St Se Ste B, Albany, OR 97322 Phone: 541-207-7431 Fax: 541-644-5071 | |
Dr. Letrice Blair, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 734 Elm St Sw, Albany, OR 97321 Phone: 541-812-5111 | |
Dr. Elizabeth Anne Heskett Bouressa, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 734 Elm St Sw, Albany, OR 97321 Phone: 541-812-5111 | |
Dr. Neda Afzali, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 734 Elm St Sw, Albany, OR 97321 Phone: 541-812-5111 Fax: 541-812-5127 | |
Dr. Lisa A. Boyd, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 734 Elm St Sw, Albany, OR 97321 Phone: 541-812-5111 Fax: 541-926-9360 | |
Dr. Matthew D. Zollinger, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 400 Nw Hickory Street, Suite 300, Albany, OR 97321 Phone: 541-812-5700 |